Document Type : Original Research Article


1 Department of Pharmaceutical Engineering, Faculty of Chemical Engineering, University of Tehran, Tehran, Iran

2 Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

3 Iran Nanotechnology Innovation Council (INIC), Tehran, Iran

4 Iranian Research Organization for Science and Technology (IROST), Tehran, Iran

5 Department of Research and Development, Vitabiotics Ltd, Tehran, Iran

6 Faculty of Pharmacy, Zanjan University of Medical Science, Zanjan, Iran

7 Department of Chemistry, Faculty of Science, University of Zanjan, Zanjan, Iran

8 Department of Chemistry, Faculty of Science, University of Maragheh, Maragheh, Iran

9 Young Researchers and Elites Club, Science and Research Branch, Islamic Azad University, Tehran, Iran

10 Department of Pharmaceutical Engineering, Faculty of Chemical Engineering, NaghsheJahan University, Isfahan, Iran

11 Engineering and Technical Faculty, Islamic Azad University, Central Tehran Branch, Tehran, Iran

12 Department of Basic Science, Maragheh University of Medical Science, Maragheh, Iran

13 Department of Microbiology, Faculty of Basic Science, Islamic Azad University of Urmia, Urmia, Iran


Bone infection (Osteomyelitis) is an inflammation of the bone that usually results in infection. Nowadays, in situ forming systems are investigated for the osteomyelitis treatment. These systems are in the form of viscous liquid, but they become solid or semi-solid and the drug is released slowly after injection into the infection site. The aim of present study was the long-term release of vancomycin using a PLGA system loaded with drug-containing chitosan nanoparticles. The in situ formulations formed in this study were composed of three main components: polymer, water-miscible solvent, and active pharmaceutical ingredient. PLGA 504H polymer and PEG 250DME solvent with a polymer to solvent ratio of 3:1 was used to prepare the in situ forming system. Chitosan nanoparticles were designed using gelation ionic method by designing the experiment of chitosan nanoparticles with encapsulation efficiency of 51% and drug loading of 25%. Then, by adding different ratios of released drug to loaded drug through nanoparticles in the system, their release profile was examined. The results revealed that adding chitosan nanoparticles reduced burst release by 44% and increased the release time. In this system, the drug can be added to the polymer solution in different proportions of the free form and the drug-containing nanoparticle. Furthermore, in this system, it is possible to use the combination of different drugs in free form or loaded in nanoparticles to improve the treatment process in the system. The use of biodegradable polymers eliminates the need for surgery in the use of this medicinal system. Moreover, this system is biocompatible and non-toxic due to the non-use of organic solvent in the preparation of the system and the use of PEG 250 DME solvent.

Graphical Abstract

Vancomycin prolonged release via PLGA system loaded with drug-containing chitosan nanoparticles as a novel in situ forming drug delivery system


Main Subjects

[1] S. Chihara, J. Segreti, Osteomyelitis, Dis Mon., 2010, 56, 6-31‎‏.‏‎ [Crossref], [Google Scholar], [Publisher]‎
[2] K. Malizos, J. Sarma, R. A. Seaton, M. Militz, F. Menichetti, G. Riccio, J. Gaudias, U. Trostmann, R. Pathan, K. Hamed, Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry, Eur. J. Clin. Microbiol. Infect Dis.,  2016, 35, 111-118‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
[3] F. Tao, S. Ma, H. Tao, L. Jin, Y. Luo, J. Zheng, W. Xiang, H. Deng, Chitosan-based drug delivery systems: From synthesis strategy to osteomyelitis treatment – A review, Carbohydr. Polym., ‎‎2021, 251, 117063‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
[4] H. Aghazadeh, F. Tamaddon, M. Ouni, P. Taheri, T. Sangchooli, Microencapsulation of herbal ‎bioactive drug by ‎Chlorella Vulgaris microalgae as a nano-‎formulation for drug delivery to cells. ‎Eurasian Chem. Commun., 2023, 5, 327-334‎‏.‏‎ ‎ ‎[Crossref], [Google Scholar], [Publisher]
[5] C. Fölsch, M. Federmann, S. Lakemeier, K.D. Kuehn, C. Kittinger, M. Kerwat, S. Fuchs-Winkelmann, J.R.J. Paletta, P.P. Roessler, Systemic antibiotic therapy does not significantly improve outcome in a rat model of implant-associated osteomyelitis induced by Methicillin susceptible Staphylococcus aureus, Arch Orthop Trauma Surg., 2016, 136, 585-592‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
[6] Z. Zhou, Q. Yao, L. Li, X. Zhang, B. Wei, L. Yuan, L. Wang, Antimicrobial activity of 3D-printed poly(ε-caprolactone) (PCL) composite scaffolds presenting vancomycin-loaded polylactic acid-Glycolic acid (PLGA) Microspheres, Med. Sci. Monit., 2018, 24, 6934-6945‎‏.‏‎ ‎ ‎[Crossref], [Google Scholar], [Publisher]
[7] M. Vallet‐Regí, D. Lozano, B. González, I.‏ Izquierdo‐Barba, Biomaterials against bone infection, Adv. Healthc. Mater., 2020, 9, 2000310‎‏.‏‎ ‎ [Crossref], [Google Scholar], [Publisher]‎
[8] F. Liu, X. Cheng, L. Xiao, Q. Wang, K. Yan, Z. Su, L. Wang, C. Ma, Y. Wang, Inside-outside Ag nanoparticles-loaded polylactic acid electrospun fiber for long-term antibacterial and bone regeneration, Int. J. Biol. Macromol., 2021, 167, 1338-1348‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
[9] S. Kempe, K. Mäder, In situ forming implants — an attractive formulation principle for parenteral depot formulations, J. Control Release, 2012, 161, 668-679‎‏.‏‎‎ ‎[Crossref], [Google Scholar], [Publisher]
[10] S. Supper, N. Anton, J. Boisclair, N. Seidel, M. Riemenschnitter, C. Curdy, T. Vandamme, Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery, ‎Eur. J. Pharm. Biopharm., 2014, 88, 361-373‎‏.‏‎ [Crossref], [Google Scholar], [Publisher]
[11] M. Mahmoudian, F. Ganji, Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels, Prog Biomater., 2017, 6, 49-56‎‏.‏‎ [Crossref], [Google Scholar], [Publisher]
[12] C. Packhaeuser, J. Schnieders, C. Oster, T. Kissel, In situ forming parenteral drug delivery systems: an overview, Eur. J. Pharm. Biopharm., 2004, 58, 445-455‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]‎
[13] N. HB, S. Bakliwal, S. Pawar, In-situ gel: new trends in controlled and sustained drug delivery system, Int. J. Pharmtech Res., 2010, 2, 1398-1408. ‎[Pdf], [Google Scholar], [Publisher]
[14] L.H. Cobb, E.M. McCabe, L.B. Priddy, Therapeutics and delivery vehicles for local treatment of osteomyelitis, Orthop Res., 2020, 38, 2091-2103‎‏.‏‎ [Crossref], [Google Scholar], [Publisher]
[15] A.M. Nejres, H.K. Ali, S.P. Behnam, Y.F. Mustafa, Potential effect of ammonium chloride on the optical physical properties of polyvinyl alcohol, Syst. Rev. Pharm., 2020, 11, ‎‎726-732. ‎‎[Crossref], [Google Scholar], [Publisher]
[16] L. Liu, Q. Gao, X. Lu, H. Zhou, In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration, Asian J. Pharm. Sci., 2016, 11, 673-683. ‎[Crossref], [Google Scholar], [Publisher]
[17] A.B. Roomi, G. Widjaja, D. Savitri, A. Turki Jalil, Y. Fakri Mustafa, L. Thangavelu, ‎ G. Kazhibayeva, W. Suksatan, S. Chupradit, S. Aravindhan, SnO2:Au/carbon quantum dots nanocomposites: synthesis, characterization, and antibacterial activity, J. Nanostructures, ‎‎2021, 11, 514-523. ‎[Crossref], [Google Scholar], [Publisher]
[18] F. Tan, Y. Zhu, Z. Ma, M. Al-Rubeai, Recent advances in the implant-based drug delivery in otorhinolaryngology, Acta Biomater., 2020, 108, 46-55‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
[19] M. Wang, T. Tang, Surface treatment strategies to combat implant-related infection from the beginning, J. Orthop. Translat., 2019, 17, 42-54.‎ ‎[Crossref], [Google Scholar], [Publisher]
[20] H. Aghazadeh, S.M.A. Ebnetorab, N. Shahriari, H. Ghaffari, EF. Gheshlaghi, P. Taheri, Design and production of DNA-based electrochemical and biological biosensors for the detection and measurement of gabapentin medication in clinical specimens, J. Electrochem. Soc., 2022, 169, 077517.‎ ‎[Crossref], [Google Scholar], [Publisher]
[21] P. Nooeaid, W. Li, J.A. Roether, V. Mourino, O.M. Goudouri, D.W. Schubert, A.R. Boccaccini, Development of bioactive glass based scaffolds for controlled antibiotic release in bone tissue engineering via biodegradable polymer layered coating, Biointerphases, 2014, 9, 041001.‎ ‎[Crossref], [Google Scholar], [Publisher]
[22] E. Cevher, Z. Orhan, L. Mülazımoğlu, ‏ ‏D. Şensoy, M. Alper, A. Yıldız, Y. Özsoy, Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres, ‎Int. J. Pharm., 2006, 317, 127-135‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
[23] T. Cerchiara, A. Abruzzo, M. Di Cagno, F. Bigucci, A. Bauer-Brandl, C. Parolin, B. Vitali, MC. Gallucci, B. Luppi, Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods, Eur. J. Pharm. Biopharm., 2015, 92, 112-119‎‏.‏‎ ‎ ‎[Crossref], [Google Scholar], [Publisher]
[24] P. Calvo, C. Remuñán-López, J.L. Vila-Jato, M. Alonso, Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers, J. Appl. Polym. Sci., ‎‎1997, 63, 125-132‎‏.‏‎ ‎[Crossref], [Google Scholar], [Publisher]
Copyright © 2023 by SPC (Sami Publishing Company) + is an open access article distributed under the Creative Commons Attribution License(CC BY)  license  (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

[25] T. Chantadee, P. Sawangsri, W. Santimaleeworagun, T. Phaechamud, Vancomycin hydrochloride-loaded stearic acid/lauric acid in situ forming matrix for antimicrobial inhibition in patients with joint infection after total knee arthroplasty, Mater. Sci. Eng. C. Mater. Biol. Appl., 2020, 115, 110761.‎ ‎[Crossref], [Google Scholar], [Publisher]
[26] M. Darestani‐Farahani, E. Vasheghani‐Farahani, H. Mobedi, F. Ganji, The effect of solvent composition on vancomycin hydrochloride and free base vancomycin release from in situ forming implants, Polym. Adv. Technol., 2016, 27, 1653-1663.‎ ‎[Crossref], [Google Scholar], [Publisher]